> top > docs > PMC:7104244 > spans > 2335-3849 > annotations

PMC:7104244 / 2335-3849 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
35 274-284 Species denotes SARS-CoV-2 Tax:2697049
36 405-415 Species denotes SARS-CoV-2 Tax:2697049
37 707-715 Species denotes patients Tax:9606
38 1129-1134 Species denotes human Tax:9606
39 1406-1414 Species denotes patients Tax:9606
40 17-25 Disease denotes COVID-19 MESH:C000657245
41 673-698 Disease denotes gastrointestinal symptoms MESH:D012817
42 728-736 Disease denotes COVID-19 MESH:C000657245
43 1256-1265 Disease denotes infection MESH:D007239

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T69 17-25 SP_7 denotes COVID-19
T68 118-123 UBERON:0001988 denotes stool
T67 212-217 UBERON:0001988 denotes stool
T66 274-284 SP_7 denotes SARS-CoV-2
T65 357-363 UBERON:0000479 denotes tissue
T64 405-415 SP_7 denotes SARS-CoV-2
T63 432-438 UBERON:0001988 denotes faeces
T62 449-454 UBERON:0001988 denotes stool
T61 491-496 NCBITaxon:10239 denotes virus
T60 541-558 UBERON:0000065 denotes respiratory tract
T59 599-603 UBERON:0000165 denotes oral
T58 673-689 UBERON:0001555 denotes gastrointestinal
T57 728-736 SP_7 denotes COVID-19
T56 868-876 GO:0065007 denotes regulate
T55 900-904 CHEBI:23888;CHEBI:23888 denotes drug
T54 950-956 UBERON:0000479 denotes tissue
T53 1005-1015 GO:0065007 denotes regulation
T52 1129-1134 SP_6;NCBITaxon:9606 denotes human
T51 1142-1149 UBERON:0000479 denotes tissues
T50 1166-1172 UBERON:0000479 denotes tissue

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T14 118-123 Body_part denotes stool http://purl.org/sig/ont/fma/fma64183
T15 212-217 Body_part denotes stool http://purl.org/sig/ont/fma/fma64183
T16 357-363 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T17 432-438 Body_part denotes faeces http://purl.org/sig/ont/fma/fma64183
T18 449-454 Body_part denotes stool http://purl.org/sig/ont/fma/fma64183
T19 541-558 Body_part denotes respiratory tract http://purl.org/sig/ont/fma/fma265130
T20 950-956 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T21 1135-1140 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T22 1142-1149 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T23 1166-1172 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T8 118-123 Body_part denotes stool http://purl.obolibrary.org/obo/UBERON_0001988
T9 212-217 Body_part denotes stool http://purl.obolibrary.org/obo/UBERON_0001988
T10 357-363 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T11 432-438 Body_part denotes faeces http://purl.obolibrary.org/obo/UBERON_0001988
T12 449-454 Body_part denotes stool http://purl.obolibrary.org/obo/UBERON_0001988
T13 541-558 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T14 950-956 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T15 1166-1172 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T12 17-25 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T13 274-282 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T14 405-413 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T15 1256-1265 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T25 386-389 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T26 491-496 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T27 590-591 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T28 898-899 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T29 948-949 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T30 1062-1063 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T31 1129-1140 http://purl.obolibrary.org/obo/CLO_0053065 denotes human cells
T32 1267-1268 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T33 1512-1514 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 60-65 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T5 900-904 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 1005-1015 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T8 0-376 Sentence denotes Given the global COVID-19 outbreak, we, as an international group of experts in faecal microbiota transplantation and stool banking, believe that recommendations to update (at least temporarily) the screening of stool donors are urgently needed, as the risk of transmitting SARS-CoV-2 by faecal microbiota transplantation might be higher than that in other tissue transplants.
T9 377-1266 Sentence denotes Evidence has shown that the SARS-CoV-2 can be found in faeces, and that stool samples can remain positive for the virus even when it is no longer detectable in the respiratory tract, suggesting the possibility of a faecal–oral route of transmission.9 This concept is supported by the presence of gastrointestinal symptoms in some patients affected by COVID-19.10 Another relevant issue is that faecal microbiota transplantation is not classified in the same way worldwide, as some countries regulate these transplants as a drug (eg, the USA, the UK, and France), some as a tissue (eg, Italy), and others do not provide specific regulation (eg, Australia).8 This discrepancy results in a confusing scenario, in which some countries will apply rules for human cells, tissues, or cellular or tissue-based products, and others will not, potentially contributing to the spread of the infection.
T10 1267-1514 Sentence denotes A more alarming issue is represented by the uncontrolled practice of homemade faecal microbiota transplantation, which is widespread among patients who want to try this treatment for indications outside of clinical guidelines or clinical trials.11